Article
An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw.
Biomarkers in medicine - 1 Apr 2012
La Ferla Fabio, Paolicchi Elisa, Crea Francesco, Cei Silvia, Graziani Filippo, Gabriele Mario, Danesi Romano
Abstract excerpt
BACKGROUND: Bisphosphonate (BP)-related osteonecrosis of the jaw (ONJ) is an unpredictable, debilitating adverse effect. Recently, genetic polymorphisms have arisen as promising tools to identify patients with a higher risk of drug-related adverse events. AIM: We aimed to examine the association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
